erratum · Biomolecules & Therapeutics

Erratum to "Abiraterone Acetate Attenuates SARS-CoV-2 Replication by Interfering with the Structural Nucleocapsid Protein" [Biomol Ther 30(5), 427-434 (2022)]

Jin-Soo Kim
Junpyo Gong
Seungchan An
Minsoo Noh
Seok Young Hwang
Mahmoud Kandeel
Kyeongbin Baek
Dongbum Kim
Mijeong Kang
Minyoung Kim
Sangkyu Park
Younghee Lee
Hyung‐Joo Kwon

2024Open accessKafr el-Sheikh University

Abstract

Jinsoo Kim, Seok Young Hwang, Dongbum Kim, Minyoung Kim, Kyeongbin Baek, Mijeong Kang, Seungchan An, Junpyo Gong, Sangkyu Park, Mahmoud Kandeel, Younghee Lee, Minsoo Noh and Hyung-Joo Kwon. Biomolecules & Therapeutics 2025;33:231-2. https://doi.org/10.4062/biomolther.2024.005

Research topics

interferon and immune responses
Protein Degradation and Inhibitors
Virus-based gene therapy research

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.4062/biomolther.2024.005

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.